Print

Results From Gentium S.p.A.'s Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting  
12/13/2011 10:00:41 AM

VILLA GUARDIA (COMO), Italy, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that an oral presentation on Defibrotide was presented today at the 53nd Annual Meeting and Exposition of the American Society of Hematology held at the San Diego Convention Center in California.
//-->